Integra Lifesciences Q3 Adj. EPS $0.76 Misses $0.78 Estimate, Sales $382.42M Miss $387.12M Estimate
Portfolio Pulse from Benzinga Newsdesk
Integra Lifesciences (NASDAQ:IART) reported Q3 adjusted earnings of $0.76 per share, missing the analyst consensus estimate of $0.78 by 2.56%. This is a 11.63% decrease from the same period last year. The company also reported quarterly sales of $382.42 million, missing the analyst consensus estimate of $387.12 million by 1.21%, a 0.72% decrease from the same period last year.
October 25, 2023 | 10:05 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Integra Lifesciences reported lower than expected Q3 earnings and sales, which could negatively impact the stock price in the short term.
Integra Lifesciences reported lower than expected earnings and sales for Q3. This miss could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100